Abstract
The management of psoriatic arthritis (PsA) begins with education. Each consultation provides an opportunity for the physician to counsel the patient and family about the disease and its clinical course that is unique to that individual. It is a chance for the patient and family to learn and adapt. There are also a variety of further ways for instruction to occur. In addition to regional educational symposia, there exists an international network of service organizations, focused on education and advocacy for patients with psoriasis and PsA, which are accessible by phone, mail, and the internet. Examples include the National Psoriasis Foundation and Arthritis Foundation in the USA, and a variety of similar organizations in other parts of the world.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675–679.
Clegg DO, Reda DJ, Mejias E et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2013–2020.
Mease PJ, Goffe BS, Metz J et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet 2000;356:385–390.
Gladman DD, Helliwell P, Mease PJ et al. Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 2004;50:24–35.
Willkens RF, Williams HJ, Ward JR et al. Randomized, double-blind, placebo controlled trial of lowdose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984;27:376–381.
Salvarani C, Macchioni P, Olivieri I et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 2001;28:2274–2282.
Palit J, Hill J, Capell HA et al. A multicentre doubleblind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990;29:280–283.
Jones G, Crotty M, Brooks P. Interventions for Treating Psoriatic Arthritis (Cochrane Review). Oxford: The Cochrane Library; 2001.
Kaltwasser JP, Nash P, Gladman D et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multimodal, doubleblind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004;50:1939–1950.
Smith JB, Haynes MK. Rheumatoid arthritis — a molecular understanding. Ann Intern Med 2002;136:908–922.
Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907–916.
Mease P, Kivitz A, Burch F et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arth Rheum 2004;50:2264–2272.
Antoni C, Krueger GG, de Vlam K et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005;64:1150–1157.
Mease PJ, Gladman DD, Ritchlin C et al. Adalimumab therapy in patients with psoriatic arthritis: 24-week results of a phase III study. Arthritis Rheum 2004;50:4097 (Abstract).
Mease PJ, Gladman DD, Ritchlin C et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis. Results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005;52:3279–3289.
Mease P, Ganguly R, Wanke L et al. How much improvement in pain is considered important by patients with active psoriatic arthritis? Ann Rheum Dis 2004;63(Suppl 1):391.
Mease PJ, Gladman DD, Ritchlin CT et al. Adalimumab is effective against skin and joint disease in psoriatic arthritis patients: 48-week results of ADEPT. Rheumatology 2006;45(Suppl1):68 (Abstract 129).
Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999;135:1104–1110.
Mease PJ, Gladman DD, Keystone E. Efficacy of alefacept in combination with methotrexate in the treatment of psoriatic arthritis. Ann Rheum Dis 2005;64:FRI0224.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Mease, P.J. (2008). The Management of Psoriatic Arthritis. In: Mease, P.J., Helliwell, P.S. (eds) Atlas of Psoriatic Arthritis. Springer, London. https://doi.org/10.1007/978-1-84628-897-5_7
Download citation
DOI: https://doi.org/10.1007/978-1-84628-897-5_7
Publisher Name: Springer, London
Print ISBN: 978-1-84628-896-8
Online ISBN: 978-1-84628-897-5
eBook Packages: MedicineMedicine (R0)